A Phase I Clinical Study of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 13, 2017

Primary Completion Date

December 19, 2017

Study Completion Date

December 27, 2017

Conditions

Whooping Cough

Interventions

BIOLOGICAL

Vaccine GamLPV

live intranasal vaccine for whooping cough prevention

OTHER

Placebo

Trial Locations (1)

Infectious Disease Clinical Hospital No. 1 of the Moscow Healthcare Department, Moscow

All Listed Sponsors

lead

Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation

OTHER

NCT03137927 - A Phase I Clinical Study of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine | Biotech Hunter | Biotech Hunter